RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/37237031http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37237031http://www.w3.org/2000/01/rdf-schema#comment"Activation of tumor-intrinsic innate immunity has been a major strategy for improving immunotherapy. Previously, we reported an autophagy-promoting function of the deubiquitinating enzyme TRABID. Here, we identify a critical role of TRABID in suppressing anti-tumor immunity. Mechanistically, TRABID is upregulated in mitosis and governs mitotic cell division by removing K29-linked polyubiquitin chain from Aurora B and Survivin, thereby stabilizing the entire chromosomal passenger complex. TRABID inhibition causes micronuclei through a combinatory defect in mitosis and autophagy and protects cGAS from autophagic degradation, thereby activating the cGAS/STING innate immunity pathway. Genetic or pharmacological inhibition of TRABID promotes anti-tumor immune surveillance and sensitizes tumors to anti-PD-1 therapy in preclinical cancer models in male mice. Clinically, TRABID expression in most solid cancer types correlates inversely with an interferon signature and infiltration of anti-tumor immune cells. Our study identifies a suppressive role of tumor-intrinsic TRABID in anti-tumor immunity and highlights TRABID as a promising target for sensitizing solid tumors to immunotherapy."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.org/dc/terms/identifier"doi:10.1038/s41467-023-38784-z"xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Chen H.Y."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Chen Y.H."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Lee S.R."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Huang W.S."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Chen H.H."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Kao C.H."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Wang W.J."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Wu K.P."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Chen R.H."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Chan S.J."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Yan R.L."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/author"Yeat N.Y."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/name"Nat Commun"xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/pages"3050"xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/title"TRABID inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation."xsd:string
http://purl.uniprot.org/citations/37237031http://purl.uniprot.org/core/volume"14"xsd:string
http://purl.uniprot.org/citations/37237031http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/37237031
http://purl.uniprot.org/citations/37237031http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/37237031
http://purl.uniprot.org/uniprot/#_A0A1B0GQZ6-mappedCitation-37237031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37237031
http://purl.uniprot.org/uniprot/#_A0A1L1SQ24-mappedCitation-37237031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37237031
http://purl.uniprot.org/uniprot/#_Q3TQH3-mappedCitation-37237031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37237031